Gastrointestinal bleeding in patients undergoing primary angioplasty for acute myocardial infarction: Incidence, risk factors and prognosis;Akut miyokart enfarktüsü nedeniyle primer anjiyoplasti uygulanan hastalarda gastrointestinal kanama sikliǧi, risk faktörleri ve prognoz

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 2, 2010, Pages 101-106

  Ergelen, Mehmet ^a   Uyarel, Hüseyin ^b   Soylu, Özer ^a   Ayhan, Erkan ^a   Çiçek, Gökhan ^a   Akyüz, Şükrü ^a   Yildirim, Aydin ^a   Nurkalem, Zekeriya ^a   Tezel, Tuna ^b  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Angioplasty, transluminal, percutaneous coronary adverse effects; Gastrointestinal hemorrhage etiology; Myocardial infarction therapy

Indexed keywords

ANTITHROMBOCYTIC AGENT; INOTROPIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANEMIA; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; ERYTHROCYTE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MELENA; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION; AGED; DEMOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DEMOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77952296983     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol 2007;102:2411-2416 (Pubitemid 47631776)
2. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-1206 (Pubitemid 41505393)
3. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-782 (Pubitemid 44268228)
4. Abbas AE, Brodie B, Dixon S, Marsalese D, Brewington S, O'Neill WW, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2005;96:173-176 (Pubitemid 40978568)
5. Al-Mallah M, Bazari RN, Jankowski M, Hudson MP. Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes. J Thromb Thrombolysis 2007;23:51-55 (Pubitemid 46252291)
6. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009;374:1149-1159
7. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-1823.
8. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367
9. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-154
10. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483 (Pubitemid 43855050)
11. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863 (Pubitemid 37430344)
12. Lewis JD, Shin EJ, Metz DC. Characterization of gastrointestinal bleeding in severely ill hospitalized patients. Crit Care Med 2000;28:46-50.
13. Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007;116:2793-2801
14. Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol 2007;102:2411-2416 (Pubitemid 47631776)
15. Atar S, Cannon CP, Murphy SA, Rosanio S, Uretsky BF, Birnbaum Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J 2006;151:976.e1-6
16. Follea G, Laville M, Pozet N, Dechavanne M. Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure. Haemostasis 1986;16:147-151 (Pubitemid 16088179)
17. Cadroy Y, Pourrat J, Baladre MF, Saivin S, Houin G, Montastruc JL, et al. Delayed elimination of enoxaparin in patients with chronic renal insufficiency. Thromb Res 1991;63:385-390
18. Remuzzi G. Bleeding in renal failure. Lancet 1988;1:1205-1208
19. Dauerman HL, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 2005;96:1379-1383 (Pubitemid 41566617)
20. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation 1997;96:1445-1453